Is it sufficient to maintain patients with atrial fibrillation and established PAD on a DOAC or VKA alone, or is there an additional benefit to adding an antiplatelet agent for CVD benefit?
If so, would you prefer a P2Y12i over low-dose aspirin?
Answer from: at Academic Institution
If they have medically managed PAD with no recent intervention/revascularization, anticoagulation alone should be sufficient especially if their bleeding risk is not low.
In general, most patients on anticoagulation for AF do not need to also be on anti-platelet agents for secondary preventio...
Comments
at Corewell Health Medical Center Are most providers stopping antiplatelet therapy i...
at Yale University School of Medicine I would generally continue anti-platelet Rx for 12...
Are most providers stopping antiplatelet therapy i...
I would generally continue anti-platelet Rx for 12...